Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Tuesday, 27 Jan 2026

Written Answers Nos. 1049-1069

Health Service Executive

Ceisteanna (1049)

Matt Carthy

Ceist:

1049. Deputy Matt Carthy asked the Minister for Health further to Parliamentary Question No.1024 of 12 November 2025, when a response will issue from the HSE; if it can be ensured that a person (details supplied) will receive the treatment required at Cappagh Hospital following an operation in November 2023; if it can be ensured that the necessary treatment for this patient is provided as a matter of urgency; and if she will make a statement on the matter. [6071/26]

Amharc ar fhreagra

Freagraí scríofa

Under the Health Act 2004, the Health Service Executive (HSE) is required to manage and deliver, or arrange to be delivered on its behalf, health and personal social services. The Minister for Health is prohibited from directing the HSE to provide a treatment or a personal service to any individual or to confer eligibility on any individual.

In relation to the particular query raised, I have asked the Health Service Executive to follow up on the matter and to respond to the Deputy directly, as soon as possible.

Ambulance Service

Ceisteanna (1050, 1051, 1052, 1054)

Pádraig Rice

Ceist:

1050. Deputy Pádraig Rice asked the Minister for Health if she intends to reinstate the paramedic and advanced paramedic supervisor grade within the National Ambulance Service (details supplied); and if she will make a statement on the matter. [6097/26]

Amharc ar fhreagra

Pádraig Rice

Ceist:

1051. Deputy Pádraig Rice asked the Minister for Health if she intends to introduce a dedicated ICO/EMT supervisor grade within the National Ambulance Service (details supplied); and if she will make a statement on the matter. [6098/26]

Amharc ar fhreagra

Pádraig Rice

Ceist:

1052. Deputy Pádraig Rice asked the Minister for Health if a previously agreed ratio will be implemented in the National Ambulance Service (details supplied); the reason this has not been implemented to date; and if she will make a statement on the matter. [6099/26]

Amharc ar fhreagra

Pádraig Rice

Ceist:

1054. Deputy Pádraig Rice asked the Minister for Health if a proposal will be progressed with respect to the work of supervisors within the National Ambulance Service (details supplied); and if she will make a statement on the matter. [6118/26]

Amharc ar fhreagra

Freagraí scríofa

I propose to take Questions Nos. 1050, 1051, 1052 and 1054 together.

As this is a service matter, I have asked the Health Service Executive (HSE) to respond to the Deputy directly, as soon as possible.

Question No. 1051 answered with Question No. 1050.
Question No. 1052 answered with Question No. 1050.

Health Services Waiting Lists

Ceisteanna (1053)

Seán Crowe

Ceist:

1053. Deputy Seán Crowe asked the Minister for Health the number of children on a waiting list for orthodontic treatment in the CHO7 area; the average waiting time; and the number of those waiting more than 12 months, in tabular form. [6105/26]

Amharc ar fhreagra

Freagraí scríofa

As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly.

Question No. 1054 answered with Question No. 1050.

Health Services

Ceisteanna (1055)

Louise O'Reilly

Ceist:

1055. Deputy Louise O'Reilly asked the Minister for Health if she plans to introduce screening for prostate cancer via the PSA test; and if she will make a statement on the matter. [6119/26]

Amharc ar fhreagra

Freagraí scríofa

I am committed to supporting our population screening programmes, which are a valuable part of our health service, enabling early treatment and care for many people, and improving the overall health of our population.

The Programme for Government commits to undertake a review of European screening and early detection programmes including for prostate and gastric cancers, to guide any further expansion of screening programmes. It also commits to research, implement and evaluate cancer prevention and early detection initiatives, including prostate cancer.

I would note that any proposed changes to Ireland’s screening programmes, including the potential introduction of a prostate cancer screening programme, will be facilitated through established evidence-driven protocols.

The National Screening Advisory Committee (NSAC) is the independent expert group that considers proposed changes to Ireland’s screening programmes. NSAC assesses the evidence in a robust and transparent manner and against internationally accepted criteria, before making recommendations to myself as Minister.

NSAC continues to progress work to consider the further expansion of our cancer screening programmes and has submitted several requests to the Health Information and Quality Authority (HIQA).

In December 2025, HIQA submitted the final report of its Health Technology Assessment (HTA) on the proposed extension of the BowelScreen age range eligibility to NSAC for its consideration. I look forward to receiving a recommendation from the Committee in this regard shortly.

HIQA have also commenced an evidence review to consider changes to the BreastCheck programme. This review will comprise of two elements; a proposed expansion of the age range eligibility to those aged 45-49 and 70-74, and the potential introduction of a standardised breast density notification. Both elements are anticipated to be complex and will take time to ensure that any recommendations made to me by NSAC are underpinned by a robust evidence-base.

HTAs facilitate the assessment of relevant evidence and knowledge on the effects and consequences of healthcare technologies to guide decisions regarding the appropriate use of technology and efficient allocation of resources. They involve a multi-disciplinary assessment of the clinical, economic, ethical, legal and societal perspectives that may be impacted by the introduction of a new technology. They are time intensive and rigorous processes.

In relation to prostate cancer screening, I welcome the involvement of Irish-based researchers in the EU4Health funded project, titled PRAISE-U, which is exploring the feasibility of risk-stratified screening for prostate cancer to help reduce morbidity and mortality caused by the disease, while avoiding overdiagnosis and unnecessary treatment.

Across Europe, several major research initiatives are underway to assess the feasibility of prostate cancer screening programmes, many involving Irish-based researchers. The findings from these studies will contribute to the evidence base for future consideration by NSAC. I look forward to receiving a recommendation from the Committee in due course.

Finally, I would emphasise that screening programmes are for people without symptoms. If anyone becomes aware of symptoms, or if they have concerns or worries, they should contact a medical professional immediately.

Health Services

Ceisteanna (1056)

Máire Devine

Ceist:

1056. Deputy Máire Devine asked the Minister for Health for assistance in the case of a person (details supplied).; and if she will make a statement on the matter. [6128/26]

Amharc ar fhreagra

Freagraí scríofa

As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.

Hospital Appointments Status

Ceisteanna (1057)

Catherine Ardagh

Ceist:

1057. Deputy Catherine Ardagh asked the Minister for Health the current position on the public waiting list for breast reconstruction surgery for a person (details supplied); and if she will make a statement on the matter. [6129/26]

Amharc ar fhreagra

Freagraí scríofa

As this is a service matter, I have asked the Health Service Executive to respond directly to the Deputy as soon as possible.

Hospital Procedures

Ceisteanna (1058)

Catherine Ardagh

Ceist:

1058. Deputy Catherine Ardagh asked the Minister for Health whether a person (details supplied), who qualifies for breast reconstruction surgery under the Cross-Border Directive, may access this surgery in a private hospital within the State; and if she will make a statement on the matter. [6130/26]

Amharc ar fhreagra

Freagraí scríofa

The EU Cross Border Directive (CBD) provides rules for the reimbursements to patients of the cost of receiving treatment abroad, where the patient would be entitled to such treatment in their home Member State, and supplements the rights that patients already have at EU level. Under the terms of the CBD, patients in Ireland can seek to be referred to another EU/EEA country for medical treatment that is available in the public health service in Ireland. The patient may access the overseas service in either the public or private health sector of the country they choose to receive the service in. The patient pays for the treatment and claims reimbursement from the HSE at the cost of that treatment in Ireland or the cost of it abroad, whichever is the lesser. The HSE, in fulfilling its role as the National Contact Point (NCP) in Ireland, provides information for patients on the operation of the CBD, including on its website: www2.hse.ie/services/schemes-allowances/cross-border-directive/. Where a person accesses private healthcare in Ireland there is no facility for the cost of that care to be reimbursed by the public health system.

Hospital Facilities

Ceisteanna (1059)

Pádraig O'Sullivan

Ceist:

1059. Deputy Pádraig O'Sullivan asked the Minister for Health when the 24-acute beds for Mallow General Hospital will be operational; if there are specific timelines or factors contributing to any delays in the commissioning of these beds; and if she will make a statement on the matter. [6168/26]

Amharc ar fhreagra

Freagraí scríofa

With regard to the capital works ongoing at Mallow General Hospital, I can advise the Deputy of the following:

In 2023, a new ward block for Mallow General Hospital was constructed and opened. As part of that project, 2 additional floors were constructed to facilitate subsequent infrastructure investment at the hospital.

The subsequent development of the ward block is being progressed in 2 phases.

Phase 1 involves the fit-out of the additional space to provide a 24-bed inpatient ward. This project is underway and is anticipated to complete in Q1 2026. It is planned that the facility will be put into service immediately upon construction completion.

As a condition of the planning permission for the 24-bed inpatient ward, an extension to the existing carpark is required. A submission has been made to the local authority for planning permission, and it is expected that a tender for these works will issue in Q2 2026.

Phase 2 of the ward block development involves the fit-out of the existing Ground Floor shell & core space to provide an Outpatient/Day Clinic ward. This ward will include 10 standard clinical rooms, and an additional 5 clinical rooms configured for the establishment and operation of an Obesity / Bariatric Clinic.

The Outpatient/Day Clinic ward project is at the detailed design stage. Subject to statutory approvals it is anticipated the project tender will be issued in Q2 2026, and the timeline for delivery can then be determined.

Health Services

Ceisteanna (1060)

Michael Cahill

Ceist:

1060. Deputy Michael Cahill asked the Minister for Health to urgently examine issues raised in respect of University Hospital Limerick and the HSE (details supplied); and if she will make a statement on the matter. [6206/26]

Amharc ar fhreagra

Freagraí scríofa

This government is fully committed to the improvement of healthcare services across the Mid West region, including at University Hospital Limerick (UHL). In the years since this tragic event occurred, there has been significant investment of funding and resources allocated to UHL and the Mid West region to help improve safety, quality and patients' experience of services.

Investment in the hospitals in the region has increased from €370 million in 2019 to €689 million in 2024. The UHL budget has almost doubled from €265 million to €507 million in the same period.

From 2019 to November 2025, staffing levels at UHL grew by 55%, an increase of 1,545 Whole Time Equivalents. This resulted in total numbers employed at UHL increasing from 2,814 to 4,359 during that period. This includes 300 more WTE doctors (including consultants), 571 more nurses and midwives, as well as 163 more health and social care professionals. Baseline implementation of the Safe Staffing Framework has also been funded in UHL. The Framework was implemented on a phased basis between 2022-2024 in all 22 medical and surgical wards and the ED.

The Capital Investment drawn down between 2020 and 2023 for the Mid West region was almost €142.2 million. €90.6 million of that figure was assigned to UHL. Through this investment, 236 new beds have opened in UHL since January 2020. This includes two fast tracked 16-bed inpatient blocks, and a new 96 bed block which opened in October 2025. In addition, enabling works are underway for the second 96 bed block at UHL.

In April 2024 the Government announced a package of measures to increase capacity, address overcrowding and deescalate the pressure experienced in the UHL Emergency Department. These measures included further increasing bed capacity, initiatives to divert patients from ED attendance as well as increasing staffing levels and further implementation of the Framework for Safe Nurse Staffing.

Also in 2024, the then Minister for Health asked HIQA to lead a review into urgent and emergency care capacity in the Mid West region. HIQA published their independent and expert review on September 30th. The report is comprehensive and includes their advice to my Department and I.

We have also listened to the passionate and determined advocacy of the people of the Mid West region and their representatives for their health services. Their input has been reflected in the consultation run by HIQA, and their report.

HIQA’s review identifies three potential options for consideration, including:

• expand capacity at the UHL Dooradoyle site (Option A)

• extend the UHL hospital campus to comprise the existing Dooradoyle site and another site (Option B)

• develop a Model 3 hospital in the HSE Mid West, providing a second ED for the region (Option C)

Alongside these options, HIQA has presented an extensive number of additional considerations, including system-wide work that must be progressed in parallel.

I have analysed all three options and the extensive findings and considerations presented by the HIQA report in detail. On the 16th of December last I presented my proposed response to Government and received approval to progress with a blend of the proposed HIQA options necessary to respond to the challenges in the Mid West.

These include:

• Additional projects and care options to maximise capacity at UHL and across the spectrum of integrated care will be delivered to achieve Option A.

• To progress Option B, I will mandate the HSE to secure an available appropriate adjacent site. This will require the setting up of standard governance structures, establishing a project board, and exploring additional opportunities to decant services away from the main Dooradoyle site.

• To progress Option C, my Department and I will develop a strategic plan for the incremental reconfiguration and investment in healthcare services in the Mid West region.

Health Services

Ceisteanna (1061)

Thomas Gould

Ceist:

1061. Deputy Thomas Gould asked the Minister for Health the number of children with an address in Cork on the CHI paediatric surgery waiting list for scoliosis who have been waiting longer than four months. [6208/26]

Amharc ar fhreagra

Freagraí scríofa

I am cognisant of the challenges families have faced in relation to paediatric orthopaedic services, in particular spinal services, and I am actively driving multiple efforts to address these challenges.

Several initiatives are underway to help improve access to services including a ringfenced theatre, additional outpatient clinics, and national and international outsourcing to maximise capacity.

As this is an operational matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.

Health Service Executive

Ceisteanna (1062)

Michael Lowry

Ceist:

1062. Deputy Michael Lowry asked the Minister for Health the approval and reimbursement status of the targeted immunotherapy zolbetuximab (Vyloy®) for the treatment of metastatic gastric adenocarcinoma (detail supplied). [6213/26]

Amharc ar fhreagra

Freagraí scríofa

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and devices; therefore, I have asked the HSE for an update in this matter.

The HSE has advised that there is a National Application, Assessment & Decision Process for new medicines which is underpinned by the 2013 Act. The HSE must comply with the relevant legislation when considering investment decisions around new medicines.

The HSE must robustly assess applications for pricing and reimbursement to make sure that it can stretch available resources as far as possible and to deliver the best value in relation to each medicine and ultimately more medicines to Irish citizens and patients.

Pharmaceutical companies are required to submit formal applications to the HSE if they wish for their medicines to be added to the list of reimbursable items / funded via hospitals. The decision of pharmaceutical companies to market licensed medicines i.e. whether or not to submit a formal application, is outside the control of the Department of Health, the Minister for Health and the HSE. The national assessment and decision process cannot commence in the absence of a pricing and reimbursement application submission to the HSE by the pharmaceutical company.

The HSE have advised as of 22 January 2026, a pricing and reimbursement application has not been received for Zolbetuximab (Vyloy®).

The State has successfully negotiated a new Agreement in Principle on the Supply and Pricing of Medicines with IPHA, which will commence from this year and last until the end of 2029. The agreement provides a commitment and a structured process towards achieving a 180-day timeline, for completing health technology assessments (HTA) and reimbursement decisions. The structured process will be implemented over the lifetime of the Agreement.

General Practitioner Services

Ceisteanna (1063)

Michael Cahill

Ceist:

1063. Deputy Michael Cahill asked the Minister for Health to address the need for a fulltime South Doc service in rural County Kerry (details supplied); and if she will make a statement on the matter. [6224/26]

Amharc ar fhreagra

Freagraí scríofa

As this is a service matter, I have asked the HSE to reply to the Deputy directly as soon as possible.

Hospital Appointments Status

Ceisteanna (1064)

Niamh Smyth

Ceist:

1064. Deputy Niamh Smyth asked the Minister for Health if she will review the case of a person (details supplied) who is awaiting an urgent consultant appointment at Cappagh Hospital; the current waiting time for such appointments; and if she will make a statement on the matter. [6225/26]

Amharc ar fhreagra

Freagraí scríofa

Under the Health Act 2004, the Health Service Executive (HSE) is required to manage and deliver, or arrange to be delivered on its behalf, health and personal social services. The Minister for Health is prohibited from directing the HSE to provide a treatment or a personal service to any individual or to confer eligibility on any individual.

In relation to the particular query raised, as this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.

Health Services

Ceisteanna (1065)

David Cullinane

Ceist:

1065. Deputy David Cullinane asked the Minister for Health the number of people waiting for diagnostic tests at the end of quarter 4, 2025, in tabular form. [6227/26]

Amharc ar fhreagra

Freagraí scríofa

Waiting times for radiology and diagnostic services have been recognised as an issue for some time. This Government is committed to the implementation of the 2017 Sláintecare Report, which includes a maximum waiting time target of 10 days for a diagnostic test.

The roll out of National digital platforms such as the National Integrated Medical Imaging System (NIMIS) and the National Laboratory Information System (MedLIS) are reducing duplication, improving diagnostic accuracy, and enabling secure, rapid information sharing across all public hospitals. In 2026, the use of digital diagnostic tools will be further expanded under the Productivity and Savings Taskforce Action Plan to increase the number of diagnostic scans, alongside measures to improve the utilisation of diagnostic equipment supporting increased diagnostic capacity.

The NTPF is working to support access to radiology and in October 2024 it published a National Radiology Diagnostic Waiting List Management Protocol. As well as ensuring that patients seeking access to Radiology Diagnostic services are administratively managed in a safe, timely, fair, and equitable manner whilst waiting, the protocol will facilitate improved data collection and reporting about patients on Radiology Diagnostic waiting lists.

In the interim, the information that is currently being collected as part of a pilot project is being tested and validated at hospital, hospital region and national level and as such should not be used/reported without the context of the caveats set out below:

Data is subject to inclusions and exclusions which are documented in the Data Profile Document. This document is available from Acute Operations and has been circulated to all Hospital Regions.

Data contains urgent, routine and surveillance/planned activity which is currently not broken down in detail, as such this includes surveillance/planned activity which may not be exceeding planned date.

Data is still undergoing validation at Hospital and Hospital Region level. Data does not take into account local nuances at site level (Site profile developed to support understanding of same).

The purpose of this aggregate data is to provide a National Level overview of the number of patients waiting for modalities of CT, MRI and Ultrasound.

This report is not intended to be used for the active management of hospital diagnostics waiting list, local reports and mechanisms should continue to be used for the management of diagnostics waiting lists at hospital level.

The NTPF provides my Department with quarterly reports which set out waiting list data for CT, MRI and Ultrasound by hospital and time band. The quarterly report for quarter 4 of 2025 has not yet been provided to my Department, and the Deputy has been provided with the most recent report available for quarter 3 of 2025 in response to previous parliamentary questions.

Health Services

Ceisteanna (1066)

David Cullinane

Ceist:

1066. Deputy David Cullinane asked the Minister for Health the total spend by the HSE and section 38 hospitals on agency staffing and recruitment service in each of the years 2019 to 2025, in tabular form. [6228/26]

Amharc ar fhreagra

Freagraí scríofa

As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.

Health Services

Ceisteanna (1067)

David Cullinane

Ceist:

1067. Deputy David Cullinane asked the Minister for Health the total cost of medical negligence litigation, including settlements, awards, and legal fees, in each of the years 2014 to 2025, in tabular form. [6229/26]

Amharc ar fhreagra

Freagraí scríofa

The State Claims Agency (SCA) has a statutory remit to manage personal injury and third-party property damage claims on behalf of State authorities. The SCA has provided me with the information set out below.

The information contained within this response was extracted from the National Incident Management System (NIMS) as per the below criteria.

The following table contains the transactional amounts paid by the State Claims Agency under the Clinical Indemnity Scheme, that are associated with claims and a small number of incidents and inquests. It excludes claims recorded against other designated schemes. This amount includes damages, agency legal and other costs, and plaintiff legal costs and is inclusive of VAT, where applicable.

It includes payments between 01/01/2025 and 31/12/2025 and is correct as of 01/01/2026.

Please note that as per the responses issued to PQ 52571/25 and PQ 73633/25, amounts paid between 01/01/2014 and 31/12/2024 remain unchanged from those provided in response to PQ 38143/25 and PQ 3529/25. Please refer to the published information for further details.

Transaction Reporting Year

Amount paid

2025

€319,703,295

Health Services

Ceisteanna (1068)

David Cullinane

Ceist:

1068. Deputy David Cullinane asked the Minister for Health the average time to admission, waiting-time distribution, and the number leaving without being seen via emergency departments, for each quarter of each full year 2022–2025, statewide and by hospital, with separate figures for all patients and patients aged 75 years and over, in tabular form. [6230/26]

Amharc ar fhreagra

Freagraí scríofa

As this is a service matter, I have asked the HSE to respond to the deputy directly.

Health Services

Ceisteanna (1069)

David Cullinane

Ceist:

1069. Deputy David Cullinane asked the Minister for Health the number of hospital-initiated scheduled care cancellations, for each quarter of each full year 2022–2025, by hospital and appointment/procedure type, broken down by adult and child, in tabular form. [6231/26]

Amharc ar fhreagra

Freagraí scríofa

I fully acknowledge the distress and inconvenience for patients and their families when hospital appointments are cancelled, particularly in the case of clinically urgent procedures.

While every effort is made to avoid cancellation or postponement of planned procedures, the Health Service Executive (HSE) has advised that planned procedures and operations can be postponed or cancelled for a variety of reasons including capacity issues due to increased unscheduled care demand.

Patient safety remains at the centre of all hospital activity and elective care scheduling. To ensure services are provided in a safe, clinically aligned and prioritised way, hospitals follow HSE clinical guidelines and protocols.

Cancelled hospital procedures/appointments are, where appropriate, rescheduled as early as possible with priority given to patients requiring time-sensitive and urgent treatment. Patients that are cancelled are rescheduled with the next available appointment based on their clinical prioritisation, with urgent patients prioritised for access.

In relation to the particular queries raised, as these are service matters, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.

Roinn